Medical News

RSS

Transgenomic expands EU distribution of SURVEYOR Scan K-RAS CE IVD mutation detection kit

Transgenomic, Inc. today announced that it completed the requirements for CE IVD labeling and has significantly expanded distribution of its SURVEYOR® Scan K-RAS mutation detection kit throughout most of the European Union. The SURVEYOR Scan K-RAS CE IVD kit is a member of Transgenomic's family of mutation detection kits, which features proprietary SURVEYOR endonuclease technology.

14 Sep 2010

Switching ACS patients to Effient therapy reduces Maximum Platelet Aggregation

A study evaluating the level of platelet aggregation achieved after switching from Plavix (clopidogrel) 75 mg once-daily maintenance dosing plus aspirin to Effient(prasugrel) 10 mg once-daily maintenance dosing (MD) in patients with acute coronary syndrome (ACS) was published today in the Journal of the American College of Cardiology.

14 Sep 2010

New 'Therapeutic Hypothermia and Temperature Management' journal

Therapeutic Hypothermia and Temperature Management, a new quarterly peer-reviewed journal from Mary Ann Liebert, Inc., publishers, covers all aspects of hypothermia and temperature considerations relevant to this exciting field, including its application in cardiac arrest, spinal cord and traumatic brain injury, stroke, myocardial ischemia, neurogenic fever, emergency medicine, ICU management, anesthesiology, pediatrics, and much more.

14 Sep 2010

Experts warn dip in antibiotic R&D could lead to treatment challenges

The 50th annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) kicked off in Boston on Sunday with experts warning that a "slowdown" in research on antibiotic development could result in treatment challenges.

14 Sep 2010

Human cytomegalovirus cloned

A team of Welsh scientists have successfully cloned a human virus offering new hope for the treatment of potentially life-threatening diseases.

14 Sep 2010

ADHD medication improves childhood cancer survivors: Research

A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a multicenter trial led by St. Jude Children's Research Hospital investigators.

14 Sep 2010

News outlets examine MDGs challenges: Communicating to public, NGOs charge draft declaration falls short

AllAfrica.com reports on a "fellowship hosted by the U.N. Foundation" last week "to educate the media about progress that has been made on the Millennium Development Goals (MDGs) thus far and what still needs to be done before the 2015 target date for achieving them."

14 Sep 2010

Neural inhibition critical in ability to make choices

A new University of Colorado at Boulder study sheds light on the brain mechanisms that allow us to make choices and ultimately could be helpful in improving treatments for the millions of people who suffer from the effects of anxiety disorders.

14 Sep 2010

Seattle Times examines how Gates Foundation's goal to eradicate malaria is affecting research

The Seattle Times examines how the Bill & Melinda Gates Foundation's goal to eradicate malaria is shaping aspects of global research.

14 Sep 2010

Roche granted FDA 510(k) clearance for cobas 8000 modular analyzer series

Roche Diagnostics announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum Work Area solution designed for diagnostic laboratories with a workload of 3-15 million clinical chemistry / immunochemistry tests per year.

From Roche Sequencing and Life Science 14 Sep 2010

AGTC receives grant to evaluate Phase II Human Clinical Trial for LCA retinal disease

Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.

14 Sep 2010

Tony Blair's 'Commission for Africa' issues new report: Africa experiences economic growth, donors need to honor commitments

The Commission for Africa, a panel set up by former British Prime Minister Tony Blair, issued a report Monday which says international donors must follow up on aid commitments to Africa and help the continent address new challenges,

14 Sep 2010

AIDS advocates call for African Governments to spend more of their own funds on health

Doctors and AIDS activists on Friday urged African governments to fulfill a decade-old pledge to spend more of their own money on health if they want international help in fighting AIDS.

14 Sep 2010

AskBio enters patent license agreement with Pfizer for HCV therapy

Asklepios BioPharmaceutical, Inc., a privately-owned clinical-stage biotechnology company, announced today it has entered into a patent license agreement with Pfizer, Inc. granting Pfizer access to certain proprietary gene-delivery platform technologies developed by AskBio, for use in developing novel therapies for patients with Hepatitis C virus (HCV).

14 Sep 2010

African Green Revolution Forum concludes with 'Green Revolution' action plan

Participants at the first meeting of the African Green Revolution Forum (AGRF) - which wrapped up recently in Accra, Ghana - drew up a "Green Revolution" action plan aimed at ensuring food security in Africa, SciDev.Net reports. The forum is the result of a challenge, issued by former U.N. Secretary General Kofi Annan, which calls on the private and public sectors to work together to achieve the Millennium Development Goals.

14 Sep 2010

Sanofi Pasteur files Fluzone Intradermal influenza virus vaccine sBLA with FDA

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has filed a Supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) for Fluzone® Intradermal (Influenza Virus Vaccine). The file has been accepted by the FDA and an action date is anticipated in the first half of 2011.

From BD (Becton, Dickinson and Company) 14 Sep 2010

Repetitive transcranial magnetic stimulation helps to regain motor function in partially paralyzed patients

Stroke patients who were left partially paralysed found that their condition improved after they received a simple and non-invasive method of brain stimulation, according to research in the September issue of the European Journal of Neurology.

14 Sep 2010

St. John Hospital commences enrollment in CONNECT trial for peripheral artery disease

St. John Hospital and Medical Center in Detroit and Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announced today the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial.

14 Sep 2010

Potassium salt intake can improve blood pressure: Study

An increased intake of 'good' potassium salts could contribute significantly to improving blood pressure at the population level. The favourable effect brought about by potassium is even estimated to be comparable with the blood pressure reduction achievable by halving the intake of 'bad' sodium salts (mostly from table salt).

14 Sep 2010

Arno Therapeutics closes private placement to advance cancer treatment

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced that it has closed a private placement of its securities resulting in gross proceeds to the company of over $15 million.

14 Sep 2010

Medical News

Transgenomic expands EU distribution of SURVEYOR Scan K-RAS CE IVD mutation detection kit

Switching ACS patients to Effient therapy reduces Maximum Platelet Aggregation

New 'Therapeutic Hypothermia and Temperature Management' journal

Experts warn dip in antibiotic R&D could lead to treatment challenges

Human cytomegalovirus cloned

ADHD medication improves childhood cancer survivors: Research

News outlets examine MDGs challenges: Communicating to public, NGOs charge draft declaration falls short

Neural inhibition critical in ability to make choices

Seattle Times examines how Gates Foundation's goal to eradicate malaria is affecting research

Roche granted FDA 510(k) clearance for cobas 8000 modular analyzer series

AGTC receives grant to evaluate Phase II Human Clinical Trial for LCA retinal disease

Tony Blair's 'Commission for Africa' issues new report: Africa experiences economic growth, donors need to honor commitments

AIDS advocates call for African Governments to spend more of their own funds on health

AskBio enters patent license agreement with Pfizer for HCV therapy

African Green Revolution Forum concludes with 'Green Revolution' action plan

Sanofi Pasteur files Fluzone Intradermal influenza virus vaccine sBLA with FDA

Repetitive transcranial magnetic stimulation helps to regain motor function in partially paralyzed patients

St. John Hospital commences enrollment in CONNECT trial for peripheral artery disease

Potassium salt intake can improve blood pressure: Study

Arno Therapeutics closes private placement to advance cancer treatment

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News